AB063. Potential synergistic effect by combination of PED-4 and PED-5 inhibitors plus theophylline in lung cancer?
Author(s) -
Kalliopi Domvri,
Wolfgang HohenforstSchmidt,
Νικόλαος Ζώγας,
Savvas Petanidis,
Paul Zarogoulidis,
Κonstantinos Porpodis,
Efi Kioseoglou
Publication year - 2016
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2016.ab063
Subject(s) - theophylline , lung cancer , medicine , pharmacology , drug , cancer , treatment of lung cancer , phosphodiesterase , combination therapy , cancer research , oncology , biology , enzyme , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom